Sigrid Therapeutics
  • Sigrid Therapeutics
  • Quotes
  • Share:
  • Subscribe:
  • news.cision.com/
  • Sigrid Therapeutics/
  • Sigrid Therapeutics Secures $4 Million in Oversubscribed Funding Round to Tap Into Booming Obesity and Diabetes Market/
  • Sana Alajmovic CEO Sigrid Therapeutics

Sana Alajmovic CEO Sigrid Therapeutics

Tue, Oct 31, 2023 08:30 CET

Low resolution

Medium resolution

Original resolution

Subscribe

Related Releases

Consumer Test-Launch of SIGRID's Glucose Stabiliser proves major success Tue, Jan 07, 2025 08:30 CET
Sigrid Therapeutics Secures US Patent for Groundbreaking SiPore[®] Technology in Blood Sugar Management Mon, Dec 02, 2024 08:30 CET
Sigrid Therapeutics Announces Last Patient Last Visit in SHINE Clinical Trial Evaluating SiPore21® Gel for Sustained Blood Sugar Control Mon, Nov 04, 2024 08:30 CET
©Cision
Privacy statement | Cookies | About | Content Policy | Contact    Cision
©Cision Privacy statement Cookies About Content Policy Contact

   Cision